Enduring Material
Available April 1, 2025 ⎻ March 31, 2028
This activity has been approved for AMA PRA Category 1 Credits™.
Register for this course today!
DESCRIPTION
Infectious diseases remain a dynamic and fascinating field replete with new challenges facing outpatient primary care providers and hospital medicine practitioners alike. This program is designed to explore major infectious diseases topics of particular relevance.
This online primer course is designed to supply primary care providers, residents, infectious disease fellows, hospitalists, and advanced practice providers with a thorough understanding of various infectious diseases commonly encountered in primary care settings. Through eight comprehensive online modules, healthcare professionals will develop the knowledge and skills necessary to effectively address, manage, and prevent infectious diseases, while promoting optimal patient outcomes. The program will cover a range of topics, including HIV, latent tuberculosis, skin and soft tissue infections, community-acquired pneumonia, vaccine updates, antibiotic usage and stewardship, and sexually transmitted infections. Interactive case studies and clinical decision-making exercises will facilitate the application of acquired knowledge in real-world scenarios.
WHO SHOULD ATTEND
This activity is intended for physicians, physician assistants, nurse practitioners, nurses, advanced practice providers, and allied health professionals in the fields of emergency medicine, family practice, infectious diseases, internal medicine, and public health.
OBJECTIVES
After participating in this activity, the learner will demonstrate the ability to:
- Name the agents recommended for inclusion in first-line anti-retroviral therapy (ART) to facilitate selection of initial treatment regimens for newly diagnosed patients, and acquire knowledge of usage of ARV decision support tools.
- Describe the screening, diagnosis, and treatment of latent TB infection.
- Recognize common bacterial skin infections, viral skin infections, fungal skin infections, and parasitic skin infections, including their clinical presentation, etiology, and common pathogens, to effectively diagnose and manage these infections in primary care settings.
- Express comprehensive knowledge of antibiotic resistance, driving factors, and its global impact, to define the problem and assess its scope and relevance to primary care settings.
- Identify the clinical presentation of STIs, including symptoms, physical findings, and the appropriate use of diagnostic tests, to facilitate accurate and timely diagnosis for appropriate management and treatment.
ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates enduring material for a maximum of 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
POLICY ON PRESENTER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies in place to identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.
MAINTENANCE OF CERTIFICATION
American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) Program
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
OTHER CREDITS
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
PAs may claim a maximum of 14.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
The Johns Hopkins University has approved this activity for 14.25 contact hours for non-physicians.
PERSONALLY PROVIDED INFORMATION (PPI) POLICY
The Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) is committed to protecting the privacy of its members and customers. If you choose to provide us with personal information by sending an email, or by filling out a form with your personal information and submitting it through our Web site, we use that information to respond to your message and to help us provide you with information, products, or services that you request. We do not give, share, sell, or transfer any personal information to a third party unless required by law. The complete University privacy policy may be accessed via the OCME Web site.
JOHNS HOPKINS STATEMENT OF RESPONSIBILITY
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
COPYRIGHT INFORMATION
All rights reserved – The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.
DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information and safety profile of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
CONFIDENTIALITY DISCLAIMER for CME ACTIVITIES
I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am participating in this capacity, I may be exposed to “protected health information,” as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the “Privacy Regulations”). Protected health information is information about a person’s health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Office any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Office, telephone: 410-614-9900, e-mail: HIPAA@jhmi.edu.
Agenda / List of Talks / Index
| Module 1: HIV and HIVAssist | Approx. Minutes |
| Intro to HIV: Update on US Epidemiology, Care Cascade, Role of PCP Joyce Jones, MD, MS |
15 |
| HIV Diagnostics and Initial Testing Recommendations Joyce Jones, MD, MS |
20 |
| Prevention: Basics of PrEP including LAI, PEP Joyce Jones, MD, MS |
20 |
| Initial ART Selection Sonya Krishnan, MD, MHS |
15 |
| Managing Treatment Failure Sonya Krishnan, MD, MHS |
15 |
| Treatment Optimization/Simplification and Long-Acting Injectables Ethel Weld, MD, PhD |
15 |
| Introduction to HIVAssist Maunank Shah, MD, PhD |
15 |
| ART Primer Sonya Krishnan, MD, MHS |
10 |
| Module 2: Mycobacteria | Approx. Minutes |
| Intro to TB for PCP Maunank Shah, MD, PhD |
10 |
| LTBI Diagnosis Maunank Shah, MD, PhD |
10 |
| LTBI Treatment and Monitoring for PCP Jeff Tornheim, MD, MPH |
15 |
| What’s Hot in TB – Preparing for the Future Maunank Shah, MD, PhD |
15 |
| NTM Diseases in Immunocompetent Chris Lippincott, MD, MPH |
30 |
| NTM Diseases in Immunocompromised Elisa Ignatius, MD, MSc |
30 |
| Module 3: Skin and Soft Tissue Infections | Approx. Minutes |
| Cellulitis (non-purulent, purulent) Diagnosis and Treatment Danica Rockney, MD |
15 |
| Diabetic Foot Ulcer Marcos Schechter, MD |
15 |
| Human and Animal Bites (including Rabies ppx) Danica Rockney, MD |
15 |
| Viral Skin Infections: HSV, VZV, Molluscum Danica Rockney, MD |
15 |
| Parasitic Skin Infections: Scabies and Pediculosis Danica Rockney, MD |
15 |
| Fungal Skin Infections: Dermatophytosis and Candidiasis Danica Rockney, MD |
10 |
| Module 4: Lower Respiratory Tract Infections | Approx. Minutes |
| Community Acquired Pneumonia Overview Michael Melia, MD |
20 |
| CAP Assessment Michael Melia, MD |
15 |
| CAP – Antibiotic Selection and Management Michael Melia, MD |
15 |
| Viral LRTI: Influenza, RSV, and other Respiratory Viruses Paul Auwaerter, MD, MBA |
20 |
| Viral LRTI: COVID Paul Auwaerter, MD, MBA |
20 |
| Module 5: Vaccine Updates | Approx. Minutes |
| Vaccine Basics: Immunization Schedule, Types of Vaccines Anna Durbin, MD |
30 |
| Childhood Vaccines: Updates Anna Sick-Samuels, MD, MPH |
15 |
| Updates in Adult Immunization Recommendations Anna Durbin, MD |
20 |
| Vaccine Hesitancy Rupali Limaye, PhD |
15 |
| Module 6: Antibiotic Stewardship and Antimicrobial Resistance | Approx. Minutes |
| Antibiotic Resistance: Epidemiology Dariusz Hareza, MD |
15 |
| Antibiotic Resistance: Mechanisms Patricia Simner, PhD, MSc |
15 |
| Antibiotic Stewardship Basic Principles Sara Keller, MD, MPH |
10 |
| Management and Diagnosis of MDRO/ESBL Pranita Tamma, MD, MPH |
20 |
| New or Emerging Antibiotics Kathryn Dzintars, PharmD |
15 |
| Module 7: Sexually Transmitted Infections | Approx. Minutes |
| Epidemiology and Prevention: Overview Susan Tuddenham, MD, MPH |
10 |
| Sexual Health and the Approach to the Patient (taking a sexual history) Matthew Hamill, MBChB, PhD, MPH, MSc |
10 |
| Common STI Syndromes | |
| Urethritis, Cervicitis, Proctitis, GUD Susan Tuddenham, MD, MPH |
15 |
| Vaginitis: Trich, Vulvovaginal Candidiasis Bacterial Vaginosis Susan Tuddenham, MD, MPH |
15 |
| Organism Spotlight | |
| Syphilis Natural History and Clinical Khalil Ghanem, MD, PhD |
10 |
| Syphilis Diagnosis Khalil Ghanem, MD, PhD |
10 |
| Syphilis Clinical Management Khalil Ghanem, MD, PhD |
10 |
| Gonorrhea Susan Tuddenham, MD, MPH |
10 |
| Chlamydia/LGV Susan Tuddenham, MD, MPH |
10 |
| Mycoplasma Genitalium Susan Tuddenham, MD, MPH |
10 |
| HSV Diagnosis, Treatment, Prophylaxis, and Resistance Khalil Ghanem, MD, PhD |
10 |
| STD Prevention | |
| Screening Recommendations Matthew Hamill, MBChB, PhD, MPH, MSc |
10 |
| Barrier Methods, Partner Management, DoxyPEP Matthew Hamill, MBChB, PhD, MPH, MSc |
10 |
| Module 8: Vectors | Approx. Minutes |
| Malaria: Chemoprophylaxis and Treatment Photini Sinnis, MD |
20 |
| Malaria: Clinical Manifestations and Diagnosis Photini Sinnis, MD |
20 |
| Leishmaniasis: Presentation, Diagnosis, Management Photini Sinnis, MD |
20 |
| Trypanasomes: Presentation, Diagnosis, Management Photini Sinnis, MD |
20 |
| Vector Borne Part A: Chikungunya Anna Durbin, MD |
20 |
| Vector Borne Part B: Dengue Anna Durbin, MD |
15 |
| Vector Borne Part C: Zika Anna Durbin, MD |
15 |
Faculty Speakers
ACTIVITY DIRECTOR
Maunank Shah, MD, PhD
Professor of Medicine
JOHNS HOPKINS FACULTY
| Paul Auwaerter, MD, MBA Professor of Medicine Clinical Director of the Division of Infectious Diseases |
Rupali Limaye, PhD Associate Professor of Medicine |
| Anna Durbin, MD Associate Professor of Medicine |
Christopher Lippincott, MD, MPH Assistant Professor of Medicine Clinical Director for the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis |
| Kathryn Dzintars, PharmD Associate Pharmacy Director for the Adult Antimicrobial Stewardship Program |
Michael Melia, MD Associate Professor of Medicine Director, Infectious Diseases Fellowship Program |
| Khalil Ghanem, MD, PhD Professor of Medicine Deputy Director of Education for the Department of Medicine, Bayview Medical Center |
Anna Sick-Samuels, MD, MPH Assistant Professor of Pediatrics |
| Matthew Hamill, MBChB, PhD, MPH, MSc Assistant Professor of Medicine |
Patricia Simner, PhD, MSc Associate Professor of Pathology |
| Elisa Ignatius, MD, MSc Assistant Professor of Medicine |
Photini Sinnis, MD Professor of Medicine Deputy Director of Johns Hopkins Malaria Research Institute |
| Joyce Jones, MD, MS Assistant Professor of Medicine |
Pranita Tamma, MD, MPH Associate Professor of Pediatrics |
| Sara Keller, MD, MPH Associate Professor of Medicine |
Jeffrey Tornheim, MD, MPH Assistant Professor of Medicine |
| Sonya Krishnan, MD, MHS Assistant Professor of Medicine |
Susan Tuddenham, MD, MPH Associate Professor of Medicine |
GUEST FACULTY
| Dariusz Hareza, MD Assistant Professor of Medicine Northwestern Medicine Feinberg School of Medicine |
| Danica Rockney, MD Clinical Assistant Professor Michigan Medicine- University of Michigan |
| Marcos Schecter, MD Associate Professor Emory University School of Medicine |
FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with ineligible companies from any individual in a position to control the content of a CME activity sponsored by OCME.
The following relationships have been reported for this activity:
| NAME | ROLE | RELATIONSHIP(S) |
| Paul Auwaerter, MD | Presenter | Consulting Fee: Gilead, Shionogi Grant or research support: Pfizer, Inc. Stocks or stock options, excluding diversified mutual funds: Capricor, Johnson and Johnson |
| Anna Durbin, MD | Presenter | Honoraria: Merck and Company, Inc. Membership on Advisory Committees or Review Panels, Board Membership, etc.: Vaxxinity |
| Sara Keller, MD, MPH | Presenter | Consulting Fee: 3M Independent Contractor (included contracted research): CorMedix |
| Matthew Hamill, MBChB, MPH, MSc, PhD | Presenter | Consulting Fee: Chembio, GlaxoSmithKline, Grant or research support: Hologic Honoraria: BMJ Global Health, Clinical Care Options Royalties or Patent Beneficiary: UpToDate |
| Maunank Shah, MD, PhD | Activity Director, Presenter | Royalties or Patent Beneficiary: Scene Health Inc.
|
| Patricia Simner, PhD, MSc | Presenter | Advisor: GeneCapture Consulting Fee: BD Diangnostics, Day Zero Diagnostics, Entasis, Merck, Next Gen Diagnostics, OpGen Inc, Qiagen, Shionogi Grant or research support: Accelerate, Biomerieux, Inc, Qiagen, T2 Biosystems Inc |
| Susan Tuddenham, MD | Presenter | Grant or research support: Hologic Royalties or Patent Beneficiary: UPTODATE |
| Ethel Weld, MD, PhD | Presenter | Consulting Fee: Pfizer, Inc.
|
No one else in a position to control the content of this educational activity has disclosed a relevant financial interest or relationship with ineligible companies.
All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Note: Grants to investigators at the Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
FEES
Methods of Payment: Learners must register and submit full payment prior to the start of the activity. Registration is available through the Office of Online Education. The registration fee includes access to the online modules.
Registration Fee…………………………………………………………………………………………..$350.00
You will receive a confirmation by e-mail from the Office of Online Education.
The Johns Hopkins University reserves the right to cancel or postpone any activity due to unforeseen circumstances. In this event, the University will refund the registration fee but is not responsible for travel expenses. Additionally, we reserve the right to change the venue to a comparable venue. Under such circumstances registrants will be notified as soon as possible.
REFUND POLICY
A handling fee of $50 will be deducted for cancellation.
SYLLABUS/INSTRUCTIONAL MATERIALS
All online content will be accessible via canvas.jh.edu once you have registered.
COURSE FORMAT – METHOD OF PARTICIPATION
This enduring material is expected to take approximately 14.25 hours to complete. Once the activity is completed, you must pass the post-test and complete the evaluation with attestation to receive CME credit.
HOW TO OBTAIN CME CREDIT
CME credit for this course will be issued through the central CME system for Johns Hopkins, CloudCME. Once a learner has completed the course, their CME transcript will updated within 7 business days and can be accessed at https://hopkinscme.cloud-cme.com/. The last day to access the evaluation and attest to your credits is May 15, 2028.
RELEASE DATE
April 1, 2025
EXPIRATION DATE
March 31, 2028
PREREQUISITES FOR PARTICIPANTS
There are no prerequisites to participate in this activity.
TECHNICAL PREREQUISITES
The course will take place on the Canvas LMS (Canvas.jhu.edu). You will need the ability to log on to the platform, preferably using Google Chrome, to complete the content, which will include videos, readings, and assignments. You may also need to take part in other activities on Canvas.jhu.edu.
- Hardware requirements: computer; webcam; microphone and speakers or headset.
- Software requirements: Google Chrome web browser; access to Canvas.jhu.edu; Zoom web conferencing; Microsoft Office or similar; email
EVALUATION AND OUTCOMES SURVEY
Post activity, an online evaluation form will be available to attendees to evaluate the activity and identify future educational needs. Upon completion of the evaluation, the learner must attest to the number of hours in attendance. A certificate of attendance will be available immediately for download or print. The last day to evaluate the material and attest to your credits is May 15, 2028.
POST-TEST
A post-test will be conducted at the conclusion of the activity. A grade of at least 70% within three attempts is needed to receive CME credit.
AMERICANS WITH DISABILITIES ACT
The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.
FOR FURTHER INFORMATION
E-mail the Office of CME cmenet@jhmi.edu
For general information, please visit the activity webpage at
https://hopkinscme.cloud-cme.com/aph.aspx?P=5&EID=59126
Johns Hopkins Department of Medicine, Division of Infectious Diseases: https://hopkinsinfectiousdiseases.jhmi.edu/
To participate in additional CME activities presented by the Johns Hopkins School of Medicine Continuing Medical Education Office, please visit https://hopkinscme.cloud-cme.com
Follow us on Twitter: http://twitter.com/HopkinsCME
Facebook: http://www.facebook.com/HopkinsCME
Check out the CME mobile app CloudCME.
Organization Code: HopkinsCME
For technical assistance with website, CloudCME or credits, please visit our tech support help page: https://hopkinscme.cloud-cme.com/about/help
ACKNOWLEDGEMENT
The Johns Hopkins School of Medicine did not solicit or receive commercial funding from any ineligible companies, including pharmaceutical and medical device manufacturers, for this activity.